Park SR - Search Results

1

Integrative analysis of risk factors for immune-related adverse events of checkpoint blockade therapy in cancer.

Sung C, An J, Lee S, Park J, Lee KS, Kim IH, Han JY, Park YH, Kim JH, Kang EJ, Hong MH, Kim TY, Lee JC, Lee JL, Yoon S, Choi CM, Lee DH, Yoo C, Kim SW, Jeong JH, Seo S, Kim SY, Kong SY, Choi JK, Park SR. Sung C, et al. Among authors: park yh, park sr, park j. Nat Cancer. 2023 Jun;4(6):844-859. doi: 10.1038/s43018-023-00572-5. Epub 2023 Jun 12. Nat Cancer. 2023. PMID: 37308678

2

Association of CYP2A6 polymorphisms with S-1 plus docetaxel therapy outcomes in metastatic gastric cancer.

Kong SY, Lim HS, Nam BH, Kook MC, Kim YW, Ryu KW, Lee JH, Choi IJ, Lee JS, Park YI, Kim NK, Park SR. Kong SY, et al. Among authors: park yi, park sr. Pharmacogenomics. 2009 Jul;10(7):1147-55. doi: 10.2217/pgs.09.48. Pharmacogenomics. 2009. PMID: 19604090 Clinical Trial.

3

Cytotoxic effects of novel phytosphingosine derivatives, including N,N-dimethylphytosphingosine and N-monomethylphytosphingosine, in human leukemia cell line HL60.

Park SR, Cho HJ, Moon KJ, Chun KH, Kong SY, Yoon SS, Lee JS, Park S. Park SR, et al. Among authors: park s. Leuk Lymphoma. 2010 Jan;51(1):132-45. doi: 10.3109/10428190903383419. Leuk Lymphoma. 2010. PMID: 20001229

4

Clinical characteristics and treatment outcomes of gastric cancer patients with isolated para-aortic lymph node involvement.

Park IH, Kim SY, Kim YW, Ryu KW, Lee JH, Lee JS, Park YI, Kim NK, Park SR. Park IH, et al. Among authors: park yi, park sr. Cancer Chemother Pharmacol. 2011 Jan;67(1):127-36. doi: 10.1007/s00280-010-1296-y. Epub 2010 Mar 11. Cancer Chemother Pharmacol. 2011. PMID: 20221601

5

Phase I clinical and pharmacokinetic/pharmacogenetic study of a triplet regimen of S-1/irinotecan/oxaliplatin in patients with metastatic colorectal or gastric cancer.

Park SR, Hong YS, Lim HS, Seong MW, Kong SY, Kim SY, Park YI, Jung KH. Park SR, et al. Among authors: park yi. Cancer Chemother Pharmacol. 2013 Nov;72(5):953-64. doi: 10.1007/s00280-013-2272-0. Epub 2013 Aug 28. Cancer Chemother Pharmacol. 2013. PMID: 23982118 Clinical Trial.

6

Intraoperatively assessed macroscopic serosal changes in patients with curatively resected advanced gastric cancer: clinical implications for prognosis and peritoneal recurrence.

Yoo C, Ryu MH, Park YS, Yoo MW, Park SR, Ryoo BY, Jang SJ, Yook JH, Kim BS, Kang YK. Yoo C, et al. Among authors: park sr, park ys. Ann Surg Oncol. 2015 Sep;22(9):2940-7. doi: 10.1245/s10434-014-4352-8. Epub 2015 Jan 21. Ann Surg Oncol. 2015. PMID: 25605515 Clinical Trial.

7

Multicenter phase II study of trastuzumab in combination with capecitabine and oxaliplatin for advanced gastric cancer.

Ryu MH, Yoo C, Kim JG, Ryoo BY, Park YS, Park SR, Han HS, Chung IJ, Song EK, Lee KH, Kang SY, Kang YK. Ryu MH, et al. Among authors: park sr, park ys. Eur J Cancer. 2015 Mar;51(4):482-488. doi: 10.1016/j.ejca.2014.12.015. Epub 2015 Feb 3. Eur J Cancer. 2015. PMID: 25661103 Clinical Trial.

8

A phase II study of perioperative S-1 combined with weekly docetaxel in patients with locally advanced gastric carcinoma: clinical outcomes and clinicopathological and pharmacogenetic predictors for survival.

Kim YW, Kim MJ, Ryu KW, Lim HS, Lee JH, Kong SY, Lee JS, Choi IJ, Kim CG, Lee JY, Cho SJ, Kook MC, Park YI, Kim SK, Park SR. Kim YW, et al. Among authors: park yi, park sr. Gastric Cancer. 2016 Apr;19(2):586-596. doi: 10.1007/s10120-015-0490-3. Epub 2015 Apr 8. Gastric Cancer. 2016. PMID: 25851942 Clinical Trial.

9

Phase 2 study of adjuvant chemotherapy with docetaxel, capecitabine, and cisplatin in patients with curatively resected stage IIIB-IV gastric cancer.

Yoon S, Yoo C, Ryu MH, Kang MJ, Ryoo BY, Park SR, Yook JH, Oh ST, Yoo MW, Kim BS, Kang YK. Yoon S, et al. Among authors: park sr. Gastric Cancer. 2017 Jan;20(1):182-189. doi: 10.1007/s10120-015-0580-2. Epub 2015 Dec 11. Gastric Cancer. 2017. PMID: 26661592 Clinical Trial.

10

Associations between CYP2A6 polymorphisms and outcomes of adjuvant S-1 chemotherapy in patients with curatively resected gastric cancer.

Jeong JH, Park SR, Ahn Y, Ryu MH, Ryoo BY, Kong SY, Yook JH, Yoo MW, Kim BS, Kim BS, Kang YK. Jeong JH, et al. Among authors: park sr. Gastric Cancer. 2017 Jan;20(1):146-155. doi: 10.1007/s10120-015-0586-9. Epub 2015 Dec 29. Gastric Cancer. 2017. PMID: 26715117

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

700 results

Search Page